US national security regulators approve ChemChina takeover of Syngenta

BN MU ch P

. . . [T]he U.S. national-security regulator approved China National Chemical Corp.’s planned $43 billion takeover of Swiss seed giant Syngenta AG.

The decision in favor of China National Chemical, or ChemChina, comes amid growing opposition to Chinese investment from Europe to Australia. If completed, it would be China’s largest overseas acquisition to date.

The industry had been watching for a decision from the Committee on Foreign Investment in the U.S., or CFIUS, a government body with the power to block deals it deems a threat to the nation’s security, because about a quarter of Syngenta’s sales come from North America.

. . . [T]he deal still faces potential roadblocks from regulators in the European Union.

ADVERTISEMENT

ChemChina’s deal for Syngenta is significant not only for its size, but also what it represents for China. Acquiring the Swiss seed and pesticide giant’s intellectual property would be hugely valuable for China as it seeks to feed a growing middle class and modernize its sprawling agricultural industry.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: ChemChina-Syngenta $43 Billion Deal Approved by U.S. Security Panel

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend